182 related articles for article (PubMed ID: 2380570)
41. [Studies of complement, nephritic factor, and circulating immune complexes in chronic mesangiocapillary glomerulonephritis types I and II (author's transl)].
Mirapeix E; Yagüe J; Vives J; Revert L
Med Clin (Barc); 1981 Jun; 77(1):21-6. PubMed ID: 7253758
[TBL] [Abstract][Full Text] [Related]
42. Autoantibody to complement neoantigens in membranoproliferative glomerulonephritis.
Strife CF; Prada AL; Clardy CW; Jackson E; Forristal J
J Pediatr; 1990 May; 116(5):S98-102. PubMed ID: 2329415
[TBL] [Abstract][Full Text] [Related]
43. C3 nephritic factor and mesangiocapillary glomerulonephritis.
Williams DG
Pediatr Nephrol; 1997 Feb; 11(1):96-8. PubMed ID: 9035182
[TBL] [Abstract][Full Text] [Related]
44. A hemolytic method for the measurement of nephritic factor.
West CD
J Immunol Methods; 2008 Jun; 335(1-2):1-7. PubMed ID: 18410942
[TBL] [Abstract][Full Text] [Related]
45. C5 measurement in membranoproliferative glomerulonephritis patients with C3 nephritic factor.
Ohi H; Watanabe S; Seki M; Fujita T; Ohmori F; Hatano M
Nephron; 1987; 46(2):217-8. PubMed ID: 3600936
[No Abstract] [Full Text] [Related]
46. Detection of C3 Nephritic Factor by Hemolytic Assay.
Chabannes M; Frémeaux-Bacchi V; Chauvet S
Methods Mol Biol; 2021; 2227():147-158. PubMed ID: 33847940
[TBL] [Abstract][Full Text] [Related]
47. Use of C4d as a diagnostic tool to classify membranoproliferative glomerulonephritis.
Gupta N; Wakefield DN; Clapp WL; Garin EH
Nefrologia; 2017; 37(1):78-86. PubMed ID: 27595516
[TBL] [Abstract][Full Text] [Related]
48. Modulation of complement by autoimmune antibodies isolated from sera of patients with membranoproliferative glomerulonephritis and systemic lupus erythematosus.
Daha MR; Van Es LA
Neth J Med; 1982; 25(7):202-7. PubMed ID: 6924073
[No Abstract] [Full Text] [Related]
49. Anti-Factor B and Anti-C3b Autoantibodies in C3 Glomerulopathy and Ig-Associated Membranoproliferative GN.
Marinozzi MC; Roumenina LT; Chauvet S; Hertig A; Bertrand D; Olagne J; Frimat M; Ulinski T; Deschênes G; Burtey S; Delahousse M; Moulin B; Legendre C; Frémeaux-Bacchi V; Le Quintrec M
J Am Soc Nephrol; 2017 May; 28(5):1603-1613. PubMed ID: 28096309
[TBL] [Abstract][Full Text] [Related]
50. C4 Nephritic Factors in C3 Glomerulopathy: A Case Series.
Zhang Y; Meyer NC; Fervenza FC; Lau W; Keenan A; Cara-Fuentes G; Shao D; Akber A; Fremeaux-Bacchi V; Sethi S; Nester CM; Smith RJH
Am J Kidney Dis; 2017 Dec; 70(6):834-843. PubMed ID: 28838767
[TBL] [Abstract][Full Text] [Related]
51. [Partial lipodystrophy, hypocomplementemia and glomerulonephritis].
Habib R; Lévy M; Gubler MC; Broyer M; Habib M
Arch Fr Pediatr; 1977; 34(7 Suppl):CXCVII-CCXII. PubMed ID: 931525
[TBL] [Abstract][Full Text] [Related]
52. Recurrent allograft C3 glomerulonephritis and unsuccessful eculizumab treatment.
Kaartinen K; Martola L; Räisänen-Sokolowski A; Meri S
Clin Immunol; 2018 Feb; 187():104-106. PubMed ID: 29097196
[TBL] [Abstract][Full Text] [Related]
53. A new screening test for C3 nephritis factor based on a stable cell bound convertase on sheep erythrocytes.
Rother U
J Immunol Methods; 1982; 51(1):101-7. PubMed ID: 6921216
[TBL] [Abstract][Full Text] [Related]
54. Quantitation of C4 nephritic factor by an enzyme-linked immunosorbent assay.
Seino J; Kinoshita Y; Sudo K; Horigome I; Sato H; Narita M; Noshiro H; Kudo K; Fukuda K; Saito T
J Immunol Methods; 1990 Mar; 128(1):101-8. PubMed ID: 2324500
[TBL] [Abstract][Full Text] [Related]
55. Factor H autoantibodies in membranoproliferative glomerulonephritis.
Goodship TH; Pappworth IY; Toth T; Denton M; Houlberg K; McCormick F; Warland D; Moore I; Hunze EM; Staniforth SJ; Hayes C; Cavalcante DP; Kavanagh D; Strain L; Herbert AP; Schmidt CQ; Barlow PN; Harris CL; Marchbank KJ
Mol Immunol; 2012 Oct; 52(3-4):200-6. PubMed ID: 22721707
[TBL] [Abstract][Full Text] [Related]
56. Anti-factor B autoantibody in dense deposit disease.
Strobel S; Zimmering M; Papp K; Prechl J; Józsi M
Mol Immunol; 2010 Apr; 47(7-8):1476-83. PubMed ID: 20193965
[TBL] [Abstract][Full Text] [Related]
57. Activation of the alternative pathway of complement by monoclonal lambda light chains in membranoproliferative glomerulonephritis.
Meri S; Koistinen V; Miettinen A; Törnroth T; Seppälä IJ
J Exp Med; 1992 Apr; 175(4):939-50. PubMed ID: 1532415
[TBL] [Abstract][Full Text] [Related]
58. [An approach to research on nephritic factor and membranoproliferative glomerulonephritis].
Ohi H
Nihon Jinzo Gakkai Shi; 2012; 54(7):1006-15. PubMed ID: 23234212
[TBL] [Abstract][Full Text] [Related]
59. Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex-Mediated Membranoproliferative GN.
Iatropoulos P; Daina E; Curreri M; Piras R; Valoti E; Mele C; Bresin E; Gamba S; Alberti M; Breno M; Perna A; Bettoni S; Sabadini E; Murer L; Vivarelli M; Noris M; Remuzzi G; ;
J Am Soc Nephrol; 2018 Jan; 29(1):283-294. PubMed ID: 29030465
[TBL] [Abstract][Full Text] [Related]
60. Test for C3 nephritic factor activity by immunofixation electrophoresis.
Koch FJ; Jenis EH; Valeski JE
Am J Clin Pathol; 1981 Jul; 76(1):63-7. PubMed ID: 6789671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]